Advancements in Rheumatology Treatments

This chapter analyzes various studies focusing on the effectiveness of TNF inhibitors, IL-17 therapies, and IL-6 receptor inhibitors in treating rheumatic diseases. It highlights crucial findings related to treatment durability, cardiovascular risks associated with glucocorticoid use, and the impact of frailty on treatment outcomes. The chapter also addresses recruitment challenges for clinical trials, emphasizing the need for improved patient engagement and tailored treatment strategies.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app